Abstract
AbstractRestrictions of cross-border mobility are typically used to prevent an emerging disease from entering a country in order to slow down its spread. However, such interventions can come with a significant societal cost and should thus be based on careful analysis and quantitative understanding on their effects. To this end, we model the influence of cross-border mobility on the spread of COVID-19 during 2020 in the neighbouring Nordic countries of Denmark, Finland, Norway and Sweden. We investigate the immediate impact of cross-border travel on disease spread and employ counterfactual scenarios to explore the cumulative effects of introducing additional infected individuals into a population during the ongoing epidemic. Our results indicate that border restrictions can significantly influence the course of an epidemic, but this impact is highly contingent on the prevailing epidemic status of the involved countries. In particular, there are several instances in which the contribution of cross-border movement was found to be negligible. Our findings underscore the critical importance of accurate data and models on both epidemic progression and travel patterns in informing decisions related to inter-country mobility restrictions.
Publisher
Cold Spring Harbor Laboratory
Reference22 articles.
1. European Commission, Directorate-General for Regional, Urban Policy, J Peyrony, J Rubio, and R Viaggi. The effects of COVID-19 induced border closures on cross-border regions – An empirical report covering the period March to June 2020. Publications Office, 2021.
2. Sebastian Duchene , Leo Featherstone , Birgitte Freiesleben de Blasio , Edward C Holmes , Jon Bohlin , and John H-O Pettersson . The impact of public health interventions in the Nordic countries during the first year of SARS-CoV-2 transmission and evolution. Eurosurveillance, 26(44), 2021.
3. Genomic epidemiology of the first two waves of SARS-CoV-2 in Canada
4. Cross-border mobility in European countries: associations between cross-border worker status and health outcomes;BMC Public Health,2021
5. Travel measures in the SARS-CoV-2 variant era need clear objectives;The Lancet,2022
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献